Jopling Helen M, Odell Adam F, Hooper Nigel M, Zachary Ian C, Walker John H, Ponnambalam Sreenivasan
Endothelial Cell Biology Unit, Institute for Molecular & Cellular Biology, LIGHT Laboratories, University of Leeds, UK.
Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1119-24. doi: 10.1161/ATVBAHA.109.186239. Epub 2009 Apr 16.
Vascular endothelial growth factor receptor 2 (VEGFR2) is a receptor tyrosine kinase that regulates vascular physiology. However, mechanism(s) by which VEGFR2 signaling and trafficking is coordinated are not clear. Here, we have tested endocytic Rab GTPases for regulation of VEGFR2 trafficking and signaling linked to endothelial cell migration.
Quiescent VEGFR2 displays endosomal localization and colocalization with the Rab5a GTPase, an early endosome fusion regulator. Expression of GTP or GDP-bound Rab5a mutants block activated VEGFR2 trafficking and degradation. Manipulation of Rab7a GTPase activity associated with late endosomes using overexpression of wild-type or mutant proteins blocks activated VEGFR2 trafficking and degradation. Depletion of Rab7a decreased VEGFR2 Y1175 phosphorylation but increased p42/44 (pERK1/2) MAPK phosphorylation. Endothelial cell migration was increased by Rab5a depletion but decreased by Rab7a depletion.
Rab5a and Rab7a regulate VEGFR2 trafficking toward early and late endosomes. Our data suggest that VEGFR2-mediated regulation of endothelial function is dependent on different but specific Rab-mediated GTP hydrolysis activity required for endosomal trafficking.
血管内皮生长因子受体2(VEGFR2)是一种调节血管生理功能的受体酪氨酸激酶。然而,VEGFR2信号传导和运输的协调机制尚不清楚。在此,我们测试了内吞Rab GTP酶对VEGFR2运输以及与内皮细胞迁移相关信号传导的调节作用。
静止状态的VEGFR2表现出在内体中的定位,并与早期内体融合调节因子Rab5a GTP酶共定位。结合GTP或GDP的Rab5a突变体的表达会阻断活化的VEGFR2的运输和降解。通过野生型或突变蛋白的过表达来操纵与晚期内体相关的Rab7a GTP酶活性,会阻断活化的VEGFR2的运输和降解。Rab7a的缺失会降低VEGFR2 Y1175位点的磷酸化,但会增加p42/44(pERK1/2)丝裂原活化蛋白激酶的磷酸化。Rab5a的缺失会增加内皮细胞迁移,而Rab7a的缺失则会降低内皮细胞迁移。
Rab5a和Rab7a调节VEGFR2向早期和晚期内体的运输。我们的数据表明,VEGFR2介导的内皮功能调节依赖于内体运输所需的不同但特定的Rab介导的GTP水解活性。